Dr. Tanguy Seiwert, M.D.
Claim this profileJohns Hopkins University
Studies Squamous Cell Carcinoma
Studies Cancer
10 reported clinical trials
19 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
HPV positive
HPV negative
2Cancer
Stage IV
Stage III
HLA-A positive
Affiliated Hospitals
Clinical Trials Tanguy Seiwert, M.D. is currently running
Nivolumab + HuMax-IL8
for Head and Neck Cancer
The primary objective of this study is to assess safety and feasibility of pre-operative nivolumab in combination with BMS-986253 (anti-interleukin-8) in patients with squamous cell carcinoma of head and neck (SCCHN) who will undergo surgery.
Recruiting2 awards Phase 212 criteria
HPV-Specific T Cell Therapy
for Recurrent/Metastatic Cancer
In this study, haploidentical relatives of a patient with recurrent or metastatic HPV 16-associated malignancy will be vaccinated with a therapeutic human papillomavirus (HPV) vaccine series to generate HPV-specific leukocytes. The cancer patient with recurrent or metastatic HPV16+ cancer will then be randomized to one of two arms: 1) non-myeloablative allogeneic bone marrow transplant or 2) cluster of differentiation 8 (CD8)-depleted donor lymphocyte infusion.
Recruiting1 award Phase 1 & 214 criteria
More about Tanguy Seiwert, M.D.
Clinical Trial Related19 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Tanguy Seiwert, M.D. has experience with
- Pembrolizumab
- Nivolumab
- Docetaxel
- Sunitinib
- Sunitinib Malate
- Cemiplimab
Breakdown of trials Tanguy Seiwert, M.D. has run
Squamous Cell Carcinoma
Cancer
Cervical Cancer
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tanguy Seiwert, M.D. specialize in?
Tanguy Seiwert, M.D. focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are HPV positive.
Is Tanguy Seiwert, M.D. currently recruiting for clinical trials?
Yes, Tanguy Seiwert, M.D. is currently recruiting for 4 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Tanguy Seiwert, M.D. has studied deeply?
Yes, Tanguy Seiwert, M.D. has studied treatments such as Pembrolizumab, Nivolumab, Docetaxel.
What is the best way to schedule an appointment with Tanguy Seiwert, M.D.?
Apply for one of the trials that Tanguy Seiwert, M.D. is conducting.
What is the office address of Tanguy Seiwert, M.D.?
The office of Tanguy Seiwert, M.D. is located at: Johns Hopkins University, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.